Voltar
Revisão Revisado por pares
BIBTEX RIS

Staphylococci

2007; Elsevier BV; Volume: 29; Linguagem: Inglês

10.1016/s0924-8579(07)72175-1

ISSN

1872-7913

Autores

A.L. Casey, Peter A. Lambert, Thomas Elliott,

Tópico(s)

Antifungal resistance and susceptibility

Resumo

Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to β-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci.

Referência(s)